Phage Therapy Market

Global Phage Therapy Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027


Date: May-2021 | Id: MACRC-68510 | Geographical Scope: Global | Publisher: Mnemonics Research

The global Phage Therapy market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on Mnemonics Research newly published report.
 The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
 
 By Market Verdors:
 Phage International
 Intralytix
 C3J Therapeutics
 Adaptive Phage Therapeutics
 iNtODEWorld
 AmpliPhi Biosciences
 Phagomed
 InnoPhage
 Enbiotix
 Locus Biosciences
 Pherecydes Pharma
 Phagelux
 TechnoPhage
 Eligo Bioscience
 
 By Types:
 Oral
 External Application
 Surgical Treatment
 
 By Applications:
 Human Medicine
 Veterinary Science
 Agriculture
 
 Key Indicators Analysed
 Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
 Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
 Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
 Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology
 Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
 
 Key Reasons to Purchase
 To gain insightful analyses of the market and have comprehensive understanding of the global  market and its commercial landscape.
 Assess the production processes, major issues, and solutions to mitigate the development risk.
 To understand the most affecting driving and restraining forces in the market and its impact in the global market.
 Learn about the market strategies that are being adopted by leading respective organizations.
 To understand the future outlook and prospects for the market.
 Besides the standard structure reports, we also provide custom research according to specific requirements.

1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Phage Therapy Revenue 1.5 Market Analysis by Type 1.5.1 Global Phage Therapy Market Size Growth Rate by Type: 2021 VS 2027 1.5.2 Oral 1.5.3 External Application 1.5.4 Surgical Treatment 1.6 Market by Application 1.6.1 Global Phage Therapy Market Share by Application: 2022-2027 1.6.2 Human Medicine 1.6.3 Veterinary Science 1.6.4 Agriculture 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Phage Therapy Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter’s Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Phage Therapy Market Players Profiles 3.1 Phage International 3.1.1 Phage International Company Profile 3.1.2 Phage International Phage Therapy Product Specification 3.1.3 Phage International Phage Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.2 Intralytix 3.2.1 Intralytix Company Profile 3.2.2 Intralytix Phage Therapy Product Specification 3.2.3 Intralytix Phage Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.3 C3J Therapeutics 3.3.1 C3J Therapeutics Company Profile 3.3.2 C3J Therapeutics Phage Therapy Product Specification 3.3.3 C3J Therapeutics Phage Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.4 Adaptive Phage Therapeutics 3.4.1 Adaptive Phage Therapeutics Company Profile 3.4.2 Adaptive Phage Therapeutics Phage Therapy Product Specification 3.4.3 Adaptive Phage Therapeutics Phage Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.5 iNtODEWorld 3.5.1 iNtODEWorld Company Profile 3.5.2 iNtODEWorld Phage Therapy Product Specification 3.5.3 iNtODEWorld Phage Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.6 AmpliPhi Biosciences 3.6.1 AmpliPhi Biosciences Company Profile 3.6.2 AmpliPhi Biosciences Phage Therapy Product Specification 3.6.3 AmpliPhi Biosciences Phage Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.7 Phagomed 3.7.1 Phagomed Company Profile 3.7.2 Phagomed Phage Therapy Product Specification 3.7.3 Phagomed Phage Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.8 InnoPhage 3.8.1 InnoPhage Company Profile 3.8.2 InnoPhage Phage Therapy Product Specification 3.8.3 InnoPhage Phage Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.9 Enbiotix 3.9.1 Enbiotix Company Profile 3.9.2 Enbiotix Phage Therapy Product Specification 3.9.3 Enbiotix Phage Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.10 Locus Biosciences 3.10.1 Locus Biosciences Company Profile 3.10.2 Locus Biosciences Phage Therapy Product Specification 3.10.3 Locus Biosciences Phage Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.11 Pherecydes Pharma 3.11.1 Pherecydes Pharma Company Profile 3.11.2 Pherecydes Pharma Phage Therapy Product Specification 3.11.3 Pherecydes Pharma Phage Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.12 Phagelux 3.12.1 Phagelux Company Profile 3.12.2 Phagelux Phage Therapy Product Specification 3.12.3 Phagelux Phage Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.13 TechnoPhage 3.13.1 TechnoPhage Company Profile 3.13.2 TechnoPhage Phage Therapy Product Specification 3.13.3 TechnoPhage Phage Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.14 Eligo Bioscience 3.14.1 Eligo Bioscience Company Profile 3.14.2 Eligo Bioscience Phage Therapy Product Specification 3.14.3 Eligo Bioscience Phage Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021) 4 Global Phage Therapy Market Competition by Market Players 4.1 Global Phage Therapy Production Capacity Market Share by Market Players (2016-2021) 4.2 Global Phage Therapy Revenue Market Share by Market Players (2016-2021) 4.3 Global Phage Therapy Average Price by Market Players (2016-2021) 5 Global Phage Therapy Production by Regions (2016-2021) 5.1 North America 5.1.1 North America Phage Therapy Market Size (2016-2021) 5.1.2 Phage Therapy Key Players in North America (2016-2021) 5.1.3 North America Phage Therapy Market Size by Type (2016-2021) 5.1.4 North America Phage Therapy Market Size by Application (2016-2021) 5.2 East Asia 5.2.1 East Asia Phage Therapy Market Size (2016-2021) 5.2.2 Phage Therapy Key Players in East Asia (2016-2021) 5.2.3 East Asia Phage Therapy Market Size by Type (2016-2021) 5.2.4 East Asia Phage Therapy Market Size by Application (2016-2021) 5.3 Europe 5.3.1 Europe Phage Therapy Market Size (2016-2021) 5.3.2 Phage Therapy Key Players in Europe (2016-2021) 5.3.3 Europe Phage Therapy Market Size by Type (2016-2021) 5.3.4 Europe Phage Therapy Market Size by Application (2016-2021) 5.4 South Asia 5.4.1 South Asia Phage Therapy Market Size (2016-2021) 5.4.2 Phage Therapy Key Players in South Asia (2016-2021) 5.4.3 South Asia Phage Therapy Market Size by Type (2016-2021) 5.4.4 South Asia Phage Therapy Market Size by Application (2016-2021) 5.5 Southeast Asia 5.5.1 Southeast Asia Phage Therapy Market Size (2016-2021) 5.5.2 Phage Therapy Key Players in Southeast Asia (2016-2021) 5.5.3 Southeast Asia Phage Therapy Market Size by Type (2016-2021) 5.5.4 Southeast Asia Phage Therapy Market Size by Application (2016-2021) 5.6 Middle East 5.6.1 Middle East Phage Therapy Market Size (2016-2021) 5.6.2 Phage Therapy Key Players in Middle East (2016-2021) 5.6.3 Middle East Phage Therapy Market Size by Type (2016-2021) 5.6.4 Middle East Phage Therapy Market Size by Application (2016-2021) 5.7 Africa 5.7.1 Africa Phage Therapy Market Size (2016-2021) 5.7.2 Phage Therapy Key Players in Africa (2016-2021) 5.7.3 Africa Phage Therapy Market Size by Type (2016-2021) 5.7.4 Africa Phage Therapy Market Size by Application (2016-2021) 5.8 Oceania 5.8.1 Oceania Phage Therapy Market Size (2016-2021) 5.8.2 Phage Therapy Key Players in Oceania (2016-2021) 5.8.3 Oceania Phage Therapy Market Size by Type (2016-2021) 5.8.4 Oceania Phage Therapy Market Size by Application (2016-2021) 5.9 South America 5.9.1 South America Phage Therapy Market Size (2016-2021) 5.9.2 Phage Therapy Key Players in South America (2016-2021) 5.9.3 South America Phage Therapy Market Size by Type (2016-2021) 5.9.4 South America Phage Therapy Market Size by Application (2016-2021) 5.10 Rest of the World 5.10.1 Rest of the World Phage Therapy Market Size (2016-2021) 5.10.2 Phage Therapy Key Players in Rest of the World (2016-2021) 5.10.3 Rest of the World Phage Therapy Market Size by Type (2016-2021) 5.10.4 Rest of the World Phage Therapy Market Size by Application (2016-2021) 6 Global Phage Therapy Consumption by Region (2016-2021) 6.1 North America 6.1.1 North America Phage Therapy Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Phage Therapy Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Phage Therapy Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Phage Therapy Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Phage Therapy Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Phage Therapy Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Phage Therapy Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Phage Therapy Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Phage Therapy Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Phage Therapy Consumption by Countries 7 Global Phage Therapy Production Forecast by Regions (2022-2027) 7.1 Global Forecasted Production of Phage Therapy (2022-2027) 7.2 Global Forecasted Revenue of Phage Therapy (2022-2027) 7.3 Global Forecasted Price of Phage Therapy (2022-2027) 7.4 Global Forecasted Production of Phage Therapy by Region (2022-2027) 7.4.1 North America Phage Therapy Production, Revenue Forecast (2022-2027) 7.4.2 East Asia Phage Therapy Production, Revenue Forecast (2022-2027) 7.4.3 Europe Phage Therapy Production, Revenue Forecast (2022-2027) 7.4.4 South Asia Phage Therapy Production, Revenue Forecast (2022-2027) 7.4.5 Southeast Asia Phage Therapy Production, Revenue Forecast (2022-2027) 7.4.6 Middle East Phage Therapy Production, Revenue Forecast (2022-2027) 7.4.7 Africa Phage Therapy Production, Revenue Forecast (2022-2027) 7.4.8 Oceania Phage Therapy Production, Revenue Forecast (2022-2027) 7.4.9 South America Phage Therapy Production, Revenue Forecast (2022-2027) 7.4.10 Rest of the World Phage Therapy Production, Revenue Forecast (2022-2027) 7.5 Forecast by Type and by Application (2022-2027) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027) 7.5.2 Global Forecasted Consumption of Phage Therapy by Application (2022-2027) 8 Global Phage Therapy Consumption Forecast by Regions (2022-2027) 8.1 North America Forecasted Consumption of Phage Therapy by Country 8.2 East Asia Market Forecasted Consumption of Phage Therapy by Country 8.3 Europe Market Forecasted Consumption of Phage Therapy by Countriy 8.4 South Asia Forecasted Consumption of Phage Therapy by Country 8.5 Southeast Asia Forecasted Consumption of Phage Therapy by Country 8.6 Middle East Forecasted Consumption of Phage Therapy by Country 8.7 Africa Forecasted Consumption of Phage Therapy by Country 8.8 Oceania Forecasted Consumption of Phage Therapy by Country 8.9 South America Forecasted Consumption of Phage Therapy by Country 8.10 Rest of the world Forecasted Consumption of Phage Therapy by Country 9 Global Phage Therapy Sales by Type (2016-2027) 9.1 Global Phage Therapy Historic Market Size by Type (2016-2021) 9.2 Global Phage Therapy Forecasted Market Size by Type (2022-2027) 10 Global Phage Therapy Consumption by Application (2016-2027) 10.1 Global Phage Therapy Historic Market Size by Application (2016-2021) 10.2 Global Phage Therapy Forecasted Market Size by Application (2022-2027) 11 Global Phage Therapy Manufacturing Cost Analysis 11.1 Phage Therapy Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Phage Therapy 12 Global Phage Therapy Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Phage Therapy Distributors List 12.3 Phage Therapy Customers 12.4 Phage Therapy Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer

Add to Cart

Single User

$ 2450.00

Site License

$ 3675.00

Enterprisewide

$ 4900.00